XML 37 R12.htm IDEA: XBRL DOCUMENT
v3.25.3

Commitments | 9 Months Ended
--- | ---
Sep. 30, 2025
Commitments [Abstract] |
COMMITMENTS | NOTE 6 – COMMITMENTS In April 2025, the Company wholly owned subsidiary, INmune Bio International Ltd., entered into an agreement whereby the Company leases manufacturing space from a third party in the United Kingdom for 2 years. The lease requires payments of approximately $76,000 each quarter during the first year and $152,000 each quarter during the second year. The lease commencement date is August 2025. As of September 30, 2025, the maturities of our lease liabilities are as follows:
(in thousands, except years) |  |  |
2025 |  | $ | 68 |
2026 |  |  | 729 |
2027 |  |  | 405 |
Total lease payments |  |  | 1,202 |
Less: imputed interest |  |  | (122 | )
Present value of future lease payments |  |  | 1,080 |
Less: operating lease, current liabilities |  |  | (457 | )
Long-term operating lease liabilities |  | $ | 623 |
Weighted-average remaining lease term |  |  | 1.7 years |
Weighted-average discount rate |  |  | 12.0 | %
During the three and nine months ended September 30, 2025 the Company recognized $134,000 and $229,000, respectively, of lease expense. During the three and nine months ended September 30, 2024, the Company recognized $40,000 and $120,000, respectively, of lease expense. During April 2025, the Company’s wholly-owned subsidiary, INmune Bio International. Ltd., entered into a 2-year collaboration agreement with a vendor whereby it makes fixed payments to the vendor in exchange for services pursuant to manufacturing CORDStrom in the United Kingdom. A summary of the commitments payable for these services pursuant to the agreement is as follows as of September 30, 2025:
(in thousands, except years) |  |  |
2026 |  | $ | 1,449 |
2027 |  |  | 1,177 |
Total |  | $ | 2,626 |

X
- References No definition available. + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for commitments and contingencies. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 405 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/405-30/tableOfContent Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 440 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/450/tableOfContent Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 954 -SubTopic 440 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 440 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 440 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/440/tableOfContent + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration